Order Article Reprints

da Silva PR, do Espírito Santo RF, Melo CdO, Pachú Cavalcante FE, Costa TB, Barbosa YV, e Silva YMSdM, de Sousa NF, Villarreal CF, de Moura RO, et al. The Compound (E)-2-Cyano-N,3-diphenylacrylamide (JMPR-01): A Potential Drug for Treatment of Inflammatory Diseases. Pharmaceutics. 2022; 14(1):188. https://doi.org/10.3390/pharmaceutics14010188

da Silva, Pablo Rayff, Renan Fernandes do Espírito Santo, Camila de Oliveira Melo, Fábio Emanuel Pachú Cavalcante, Thássia Borges Costa, Yasmim Vilarim Barbosa, Yvnni M. S. de Medeiros e Silva, Natália Ferreira de Sousa, Cristiane Flora Villarreal, Ricardo Olímpio de Moura, and et al. 2022. "The Compound (E)-2-Cyano-N,3-diphenylacrylamide (JMPR-01): A Potential Drug for Treatment of Inflammatory Diseases" Pharmaceutics 14, no. 1: 188. https://doi.org/10.3390/pharmaceutics14010188

da Silva, P. R., do Espírito Santo, R. F., Melo, C. d. O., Pachú Cavalcante, F. E., Costa, T. B., Barbosa, Y. V., e Silva, Y. M. S. d. M., de Sousa, N. F., Villarreal, C. F., de Moura, R. O., & dos Santos, V. L. (2022). The Compound (E)-2-Cyano-N,3-diphenylacrylamide (JMPR-01): A Potential Drug for Treatment of Inflammatory Diseases. Pharmaceutics, 14(1), 188. https://doi.org/10.3390/pharmaceutics14010188